Grifols reports Q1 adjusted EBITDA of EUR 400M, up 14.2% from last year

TipRanks

Tue, May 13, 2025, 8:48 AM 1 min read

Net revenues reached EUR 1.786B, up 7.4% successful changeless currency. Like-for-like nett revenues accrued by 10.0% successful changeless currency. Adjusted EBITDA accrued to EUR 400M, up 14.2% successful changeless currency and +21.7% connected a changeless currency, like-for-like basis. Nacho Abia, Chief Executive Officer, commented: “Building connected our record-setting performances successful 2023 and 2024, our archetypal 4th intelligibly demonstrates continued momentum arsenic we absorption connected executing our strategical plan. Healthy underlying request successful Biopharma and crossed each parts of our business, coupled with beardown operational execution, positions Grifols (GRFS) for accordant maturation passim 2025. While we proceed to show evolving macroeconomic and argumentation developments, the long-established Grifols strategy of being section successful our largest markets, wherever we person established self-sufficient, determination plasma ecosystems with vertically integrated operations, helps to amended insulate america from broader marketplace challenges.”

• Discover companies with rock-solid fundamentals successful TipRanks' Smart Value Newsletter.

• Receive undervalued stocks, resilient to marketplace uncertainty, delivered consecutive to your inbox.

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected GRFS:

Disclaimer & DisclosureReport an Issue

• Grifols SA (GRFS) Q1 Earnings Cheat Sheet

• Grifols clarifies nary cognition of restarted treatment connected connection from Brookfield

• Grifols approves subsidiary to marque nationalist delisting acquisition connection to Biotest